IIT-Bhubaneswar, ILS innovate next-gen tuberculosis vaccine HSP 16.3 DC4
IIT-Bhubaneswar and ILS Innovate Next-Generation Tuberculosis Vaccine HSP 16.3 DC4 IIT-Bhubaneswar and ILS Innovate Next-Generation Tuberculosis Vaccine HSP 16.3 DC4 A significant breakthrough in the fight against tuberculosis (TB) has emerged from Bhubaneswar, where the Institute of Life Sciences (ILS) and the Indian Institute of Technology (IIT) Bhubaneswar have collaborated to develop a novel vaccine […]
Continue Reading